IPG Investment Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
Sell
-3,595
Closed -$264K 122
2016
Q2
$264K Hold
3,595
0.11% 100
2016
Q1
$230K Hold
3,595
0.1% 90
2015
Q4
$249K Sell
3,595
-3,860
-52% -$255K 0.11% 94
2015
Q3
$441K Buy
+7,455
New +$473K 0.21% 73

Other funds holding BMY

IPG Investment Advisors's BMY Position: Q3 2016 in Review

IPG Investment Advisors sold out of Bristol-Myers Squibb (BMY) in Q3 2016, closing a stake of 3,595 shares — an estimated $264K sold.

IPG Investment Advisors first reported a position in BMY in Q3 2015 and held it in 4 quarters. The position peaked at $441K in Q3 2015. 1,522 funds tracked by Wall St. Rank hold BMY as of Q3 2016.

  • IPG Investment Advisors reported no remaining Bristol-Myers Squibb position as of Q3 2016 after selling out during the quarter.
  • IPG Investment Advisors sold 3,595 Bristol-Myers Squibb shares in Q3 2016, an estimated $264K.
  • IPG Investment Advisors first reported a position in Bristol-Myers Squibb in Q3 2015 and held it in 4 quarters.
  • IPG Investment Advisors's Bristol-Myers Squibb position peaked at $441K in Q3 2015.
  • 1,522 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2016.

Based on IPG Investment Advisors's 13F filing for Q3 2016, filed 7 Nov 2016.